This blend combines three growth hormone–related peptides that act through complementary pathways to stimulate natural growth hormone (GH) signaling.

Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to release GH.

CJC-1295 also targets the GHRH receptor and may help prolong GH signaling and pulsatility.

Ipamorelin activates the ghrelin receptor, which can stimulate GH release without significantly increasing cortisol or prolactin in many research settings.

Together, these peptides are often explored in research related to metabolism, recovery, body composition, and growth hormone regulation.

• Add 3.0 mL bacteriostatic water → final concentration 4 mg/mL total peptide

Peptide concentration after mixing:

• Tesamorelin: 2 mg/mL
• Ipamorelin: 1 mg/mL
• CJC-1295: 1 mg/mL

This dilution allows 300–500 mcg doses to be measured easily.

• 300–500 mcg per injection

• Often administered once daily

• Some protocols may use 1–2 injections per day

• Conservative protocols typically start lower and increase gradually

• Example escalation: 300 mcg → 400 mcg → 500 mcg

• Typical research cycles run 8–12 weeks

At 4 mg/mL concentration

• 1 unit = 0.01 mL ≈ 40 mcg total peptide on a U-100 insulin syringe

Approximate breakdown per unit:

• Tesamorelin: ~20 mcg
• Ipamorelin: ~10 mcg
• CJC-1295: ~10 mcg

Example doses:

Frequency: Once daily, subcutaneous.

Most commonly administered:

• Before bedtime
• In a fasted state

Gradual escalation may help support tolerability and natural growth hormone pulsatility.

Draw 3.0 mL bacteriostatic water

Inject slowly down the vial wall (prevents foaming)

Gently swirl or roll — never shake

Label the vial with the reconstitution date

Refrigerate at 2–8 °C

This dilution provides a clean 4 mg/mL concentration, allowing easy measurement across common dosing ranges.

Example:

8 units ≈ 320 mcg

10 units ≈ 400 mcg

12 units ≈ 480 mcg

Approximate usage:

• 1 per day

• 8 weeks: 56

• 12 weeks: 84

(3 mL per vial)

• 1 vial: 3 mL

• 2 vials: 6 mL

• 2 per injection

• 8 weeks: 112

• 12 weeks: 168

Goal:

Support research into growth hormone signaling, metabolism, and recovery pathways.

Structure:

• Daily subcutaneous injections

• Gradual escalation 300 mcg → 500 mcg

• Typical cycles 8–12 weeks

Reconstitution:

3.0 mL → 4 mg/mL

Storage:

Freeze lyophilized; refrigerate reconstituted.

Lyophilized

• Store frozen at −20 °C or colder

• Protect from moisture and light

Reconstituted

• Refrigerate at 2–8 °C

• Use within 30–45 days

Handling Tips

• Allow frozen vials to reach room temperature before opening

• Avoid heat or direct sunlight

• Minimize repeated temperature fluctuations

• Stay consistent — inject at roughly the same time each day

• Starting lower may help assess individual tolerance

• Use a new sterile syringe for each injection

• Rotate injection sites (abdomen, thighs, upper arms)

• Many protocols prefer fasted injections to support GH signaling

The three peptides stimulate growth hormone release through complementary pathways.

Tesamorelin and CJC-1295 stimulate the GHRH receptor, encouraging the pituitary gland to release growth hormone.

Ipamorelin activates the ghrelin receptor, further promoting GH release while helping preserve natural hormonal balance.

Together, these peptides may help support:

• Natural GH pulsatility

• Fat metabolism

• Recovery signaling

• Sleep-related GH release

• Support for growth hormone signaling

• Improved recovery pathways

• Support for body composition research

• Enhanced metabolic signaling

• Mild water retention

• Temporary flushing or warmth

• Mild headache

• Occasional injection-site irritation

Most side effects are dose-dependent and mild.

Before injecting

• Wash hands
• Clean vial stopper
• Clean injection site
• Draw dose and remove air bubbles

How to inject

Pinch about 1 inch of skin

Insert needle at 90° (or 45° if lean)

Inject slowly

Remove needle straight out

Dispose in sharps container

After

• Refrigerate vial
• Rotate injection sites
• Monitor for redness or irritation

All peptide products sold on this website are for research, laboratory, and educational purposes only. They are not approved by the FDA or Health Canada, are not intended for human consumption, and should not be used for medical, cosmetic, or therapeutic purposes unless specifically prescribed by a licensed healthcare professional.

The information provided on this site is for informational and educational purposes only and does not constitute medical advice. Product descriptions, protocols, or references are not intended to diagnose, treat, cure, or prevent any disease.

Always consult a qualified healthcare provider before beginning any new protocol, supplement, or treatment.

By purchasing from this website, you acknowledge and agree to use these products responsibly and in accordance with all applicable laws and guidelines.